Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study

Nutrition

Volumn 36, Issue , 2017, Pages 26-32

  Akter, Shamima ^a   Eguchi, Masafumi ^b   Kurotani, Kayo ^a   Kochi, Takeshi ^b   Kashino, Ikuko ^a   Ito, Rie ^b   Kuwahara, Keisuke ^a,c   Tsuruoka, Hiroko ^b   Kabe, Isamu ^b   Mizoue, Tetsuya ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b FURUKAWA ELECTRIC CO LTD   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

25(OH)D; Cross sectional studies; Japanese; Metabolic syndrome

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; JAPANESE (PEOPLE); MALE; METABOLIC SYNDROME X; PERIODIC MEDICAL EXAMINATION; POPULATION RESEARCH; PROTEIN BINDING; TREND STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WORKER; ADMINISTRATION AND DOSAGE; ADOLESCENT; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BLOOD PRESSURE; BODY MASS; CROSS-SECTIONAL STUDY; EXERCISE; GLUCOSE BLOOD LEVEL; JAPAN; METABOLISM; MIDDLE AGED; MULTILEVEL ANALYSIS; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; WAIST CIRCUMFERENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CALCIUM, DIETARY; CHOLESTEROL; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME; MIDDLE AGED; MULTILEVEL ANALYSIS; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 85015641417     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.02.024     Document Type: Article

References (48)

1. [1] Ford, E.S., Li, C., Sattar, N., Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31 (2008), 1898–1904.
2. [2] Mottillo, S., Filion, K.B., Genest, J., Joseph, L., Pilote, L., Poirier, P., et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 56 (2010), 1113–1132.
3. [3] Esposito, K., Chiodini, P., Colao, A., Lenzi, A., Giugliano, D., Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35 (2012), 2402–2411.
4. [4] Grundy, S.M., Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28 (2008), 629–636.
5. [5] Maestro, B., Campion, J., Davila, N., Calle, C., Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47 (2000), 383–391.
6. [6] Norman, A.W., Frankel, J.B., Heldt, A.M., Grodsky, G.M., Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209 (1980), 823–825.
7. [7] Kadowaki, S., Norman, A.W., Dietary vitamin D is essential for normal insulin-secretion from the perfused rat pancreas. J Clin Invest 73 (1984), 759–766.
8. [8] Kayaniyil, S., Harris, S.B., Retnakaran, R., Vieth, R., Knight, J.A., Gerstein, H.C., et al. Prospective association of 25(OH)D with metabolic syndrome. Clin Endocrinol (Oxf) 80 (2014), 502–507.
9. [9] Gagnon, C., Lu, Z.X., Magliano, D.J., Dunstan, D.W., Shaw, J.E., Zimmet, P.Z., et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 97 (2012), 1953–1961.
10. [10] Lee, D.M., Rutter, M.K., O'Neill, T.W., Boonen, S., Vanderschueren, D., Bouillon, R., et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 161 (2009), 947–954.
11. [11] Reis, J.P., von Muhlen, D., Kritz-Silverstein, D., Wingard, D.L., Barrett-Connor, E., Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30 (2007), 1549–1555.
12. [12] Kayaniyil, S., Vieth, R., Harris, S.B., Retnakaran, R., Knight, J.A., Gerstein, H.C., et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 96 (2011), 168–175.
13. [13] Vitezova, A., Zillikens, C., van Herpt, T., Sijbrands, E., Hofman, A., Uitterlinden, A., et al. Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur J Endocrinol 172 (2015), 327–335.
14. [14] Bea, J.W., Jurutka, P.W., Hibler, E.A., Lance, P., Martinez, M.E., Roe, D.J., et al. Concentrations of the vitamin D metabolite 1,25(OH)2 D and odds of metabolic syndrome and its components. Metabolism 64 (2015), 447–459.
15. [15] Huang, C.Y., Chang, H.H., Lu, C.W., Tseng, F.Y., Lee, L.T., Huang, K.C., Vitamin D status and risk of metabolic syndrome among non-diabetic young adults. Clin Nutr 34 (2015), 484–489.
16. [16] Chon, S.J., Yun, B.H., Jung, Y.S., Cho, S.H., Choi, Y.S., Kim, S.Y., et al. Association between Vitamin D status and risk of metabolic syndrome among Korean postmenopausal women. PLoS One, 9, 2014, e89721.
17. [17] Li, L.H., Yin, X.Y., Yao, C.Y., Zhu, X.C., Wu, X.H., Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese. Endocrine 44 (2013), 465–472.
18. [18] Kim, J., Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults. Eur J Clin Nutr 69 (2015), 425–430.
19. [19] Amirbaigloo, A., Hosseinpanah, F., Sarvghadi, F., Tohidi, M., Eskandary, P.S., Azizi, F., Absence of association between vitamin D deficiency and incident metabolic syndrome: Tehran Lipid and Glucose Study. Metab Syndr Relat Disord 11 (2013), 236–242.
20. [20] Moy, F.M., Bulgiba, A., High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health, 11, 2011, 735.
21. [21] Lu, L., Yu, Z., Pan, A., Hu, F.B., Franco, O.H., Li, H., et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 32 (2009), 1278–1283.
22. [22] Ju, S.Y., Jeong, H.S., Kim do, H., Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 99 (2014), 1053–1063.
23. [23] FAO Statistics Division. Available at: http://faostat.fao.org. 2011. ftp://ftp.fao.org/FI/STAT/summary/FBS_bycontinent.pdf. Accessed June 4, 2015.
24. [24] Holick, M.F., Vitamin D deficiency. N Engl J Med 357 (2007), 266–281.
25. [25] Akter, S., Eguchi, M., Kurotani, K., Kochi, T., Pham, N.M., Ito, R., et al. High dietary acid load is associated with increased prevalence of hypertension: the Furukawa Nutrition and Health Study. Nutrition 31 (2015), 298–303.
26. [26] Nanri, A., Eguchi, M., Kuwahara, K., Kochi, T., Kurotani, K., Ito, R., et al. Macronutrient intake and depressive symptoms among Japanese male workers: the Furukawa Nutrition and Health Study. Psychiatry Res 220 (2014), 263–268.
27. [27] Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
28. [28] Kobayashi, S., Honda, S., Murakami, K., Sasaki, S., Okubo, H., Hirota, N., et al. Both comprehensive and brief self-administered diet history questionnaires satisfactorily rank nutrient intakes in Japanese adults. J Epidemiol 22 (2012), 151–159.
29. [29] Muldowney, S., Lucey, A.J., Paschos, G., Martinez, J.A., Bandarra, N., Thorsdottir, I., et al. Relationships between Vitamin D status and cardio-metabolic risk factors in young European adults. Ann Nutr Metab 58 (2011), 85–93.
30. [30] Maki, K.C., Rubin, M.R., Wong, L.G., McManus, J.F., Jensen, C.D., Marshall, J.W., et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 3 (2009), 289–296.
31. [31] Chacko, S.A., Song, Y., Manson, J.E., Van Horn, L., Eaton, C., Martin, L.W., et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 94 (2011), 209–217.
32. [32] George, J.A., Norris, S.A., van Deventer, H.E., Crowther, N.J., The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa. PLoS One, 8, 2013, e61282.
33. [33] Forouhi, N.G., Luan, J., Cooper, A., Boucher, B.J., Wareham, N.J., Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57 (2008), 2619–2625.
34. [34] Pham, N.M., Akter, S., Kurotani, K., Nanri, A., Sato, M., Hayabuchi, H., et al. Serum 25-hydroxyvitamin D and markers of insulin resistance in a Japanese working population. Eur J Clin Nutr 66 (2012), 1323–1328.
35. [35] Kirii, K., Mizoue, T., Iso, H., Takahashi, Y., Kato, M., Inoue, M., et al. Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52 (2009), 2542–2550.
36. [36] Pittas, A.G., Dawson-Hughes, B., Li, T., Van Dam, R.M., Willett, W.C., Manson, J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29 (2006), 650–656.
37. [37] Zhou, B.F., Stamler, J., Dennis, B., Moag-Stahlberg, A., Okuda, N., Robertson, C., et al. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens 17 (2003), 623–630.
38. [38] Mithal, A., Wahl, D.A., Bonjour, J.P., Burckhardt, P., Dawson-Hughes, B., Eisman, J.A., et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20 (2009), 1807–1820.
39. [39] Mitri, J., Dawson-Hughes, B., Hu, F.B., Pittas, A.G., Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94 (2011), 486–494.
40. [40] Kong, J., Li, Y.C., Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3 T3-L1 cells. Am J Physiol Endocrinol Metab 290 (2006), E916–E924.
41. [41] Rosenblum, J.L., Castro, V.M., Moore, C.E., Kaplan, L.M., Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am J Clin Nutr 95 (2012), 101–108.
42. [42] Salehpour, A., Hosseinpanah, F., Shidfar, F., Vafa, M., Razaghi, M., Dehghani, S., et al. A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr J, 11, 2012, 78.
43. [43] Szabo, A., Merke, J., Beier, E., Mall, G., Ritz, E., 1,25(Oh)2 Vitamin-D3 inhibits parathyroid cell-proliferation in experimental uremia. Kidney Int 35 (1989), 1049–1056.
44. [44] Chiu, K.C., Chuang, L.M., Lee, N.P., Ryu, J.M., McGullam, J.L., Tsai, G.P., et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49 (2000), 1501–1505.
45. [45] Li, Y.C., Kong, J., Wei, M.J., Chen, Z.F., Liu, S.Q., Cao, L.P., 1,25-Dihydroxyvitamin D-3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002), 229–238.
46. [46] Engeli, S., Schling, P., Gorzelniak, K., Boschmann, M., Janke, J., Ailhaud, G., et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?. Int J Biochem Cell Biol 35 (2003), 807–825.
47. [47] Sandhu, M.S., Heald, A.H., Gibson, J.M., Cruickshank, J.K., Dunger, D.B., Wareham, N.J., Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359 (2002), 1740–1745.
48. [48] Gomez, J.M., The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biotechnol 7 (2006), 125–132.